Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01048697Phase 4Completed
Phase 4, open-label, single-arm trial of ethambutol in Tuberculosis (TB), sponsored by Texas Tech University Health Sciences Center. Primary endpoint: Total Clearance of Ethambutol at 24 hours. Started Jan 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01048697.